AlphaGrep UK
OCUL icon

AlphaGrep UK’s Ocular Therapeutix OCUL Stock Holding History

AlphaGrep UK’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$109K Sell
14,197
-1,788
-11% -$17.5K 0.03% 719
2026
Q2 		$157K Sell
15,985
-16,941
-51% -$154K 0.05% 698
2026
Q1 		$279K Buy
+32,926
New +$314K 0.08% 548

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $135M AUM 15.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

AlphaGrep UK's OCUL Position: Q3 2026 in Review

AlphaGrep UK reduced its Ocular Therapeutix (OCUL) stake by 11% in Q3 2026, selling an estimated $17.5K and leaving 14,197 shares worth $109K. The position accounts for 0.03% of the portfolio, ranked #719.

AlphaGrep UK first reported a position in OCUL in Q1 2026 and has held it in 3 quarters since. The position peaked at $279K in Q1 2026. 184 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • AlphaGrep UK held 14,197 shares of Ocular Therapeutix worth $109K as of Q3 2026.
  • AlphaGrep UK sold 1,788 Ocular Therapeutix shares in Q3 2026, an estimated $17.5K.
  • Ocular Therapeutix made up 0.03% of AlphaGrep UK's portfolio in Q3 2026, its #719 holding.
  • AlphaGrep UK first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 3 quarters since.
  • AlphaGrep UK's Ocular Therapeutix position peaked at $279K in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.